Dieses Bild zeigt Julia Marzi

Julia Marzi

Frau Dr.

Betreuung A3
Eberhard Karls Universität Tübingen
Institute für Biomedical Engineering (IBE)
[Foto: Julia Marzi ]

Kontakt

Silcherstr 7/1
72076 Tübingen
Deutschland

  1. 2022

    1. M. Holl u. a., „Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM)“, Biomedicines, Bd. 10, Nr. 4, Art. Nr. 4, 2022, doi: 10.3390/biomedicines10040927.
    2. J. Marzi u. a., „Noninvasive Physical Plasma as Innovative and Tissue-Preserving Therapy for Women Positive for Cervical Intraepithelial Neoplasia“, Cancers, Bd. 14, Nr. 8, Art. Nr. 8, 2022, doi: 10.3390/cancers14081933.
    3. L. Becker u. a., „Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids“, International Journal of Molecular Sciences, Bd. 23, Nr. 13, Art. Nr. 13, 2022, doi: 10.3390/ijms23136956.
  2. 2021

    1. L. Becker u. a., „Raman Imaging and Fluorescence Lifetime Imaging Microscopy for Diagnosis of Cancer State and Metabolic Monitoring“, Cancers, Bd. 13, Nr. 22, Art. Nr. 22, 2021, doi: 10.3390/cancers13225682.
    2. M. Holl u. a., „Laparoscopic Peritoneal Wash Cytology-Derived Primary Human Mesothelial Cells for In Vitro Cell Culture and Simulation of Human Peritoneum“, Biomedicines, Bd. 9, Nr. 2, Art. Nr. 2, 2021, doi: 10.3390/biomedicines9020176.
    3. A. Zbinden u. a., „Collagen and Endothelial Cell Coculture Improves $\upbeta$-Cell Functionality and Rescues Pancreatic Extracellular Matrix“, Tissue Engineering Part A, Bd. 27, Nr. 13–14, Art. Nr. 13–14, Juli 2021, doi: 10.1089/ten.tea.2020.0250.
Zum Seitenanfang